MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CLYM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Climb Bio (CLYM) Ownership - Who owns Climb Bio?

Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
675.7M
P/E Ratio
N/A
Total Cash
109.56M
Projected Growth
N/A
Total Debt
479K
Revenue
N/A
Risk (Beta)
-1.36
Dividend Yield
N/A
Total Cash/Share
1.91
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CLYM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CLYM
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details